Acute coronary syndrome and chronic infection in the Cork coronary care case-control study

Heart

Volumn 91, Issue 1, 2005, Pages 19-22

  Sheehan, J ^a   Kearney, Patricia M ^a   Sullivan, S O ^a   Mongan, C ^b   Kelly, E ^b   Perry, I J ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; BODY BURDEN; CASE CONTROL STUDY; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY CARE; CONTROLLED STUDY; CORONARY RISK; CUMULATIVE BURDEN OF INFECTION; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE ISCHEMIA; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION; IRELAND; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEROLOGY;

ADULT; AGED; ANTHROPOMETRY; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPES SIMPLEX; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; VIRUS DISEASES;

EID: 10844261667     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.031799     Document Type: Article

References (32)

1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
2. Saikku P, Leinonen M, Matilla K, et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;ii:983-6.
3. Adam E, Melnick JL, Probtsfield JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;ii:291-3.
4. Danesh J, Muir J, Wong YK, et al. Risk factors for coronary heart disease and acute-phase proteins: a population-based study. Eur Heart J 1999;20:954-9.
5. Siscovick DS, Schwartz SM, Corey L, et al. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the cardiovascular health study. Circulation 2000;102:2335-40.
6. Danesh J, Whincup P, Walker M, et al. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 2000;321:208-13.
7. Gurfinkel E, Bozovich G, Daroca A, et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. ROXIS study group. Lancet 1997;350:404-7.
8. Ferguson JJ. Meeting highlights: highlights of the 51st annual scientific sessions of the American College of Cardiology. Atlanta, Georgia, USA. March 17-20, 2002. Circulation 2002;106:E24-30.
9. O'Connor CM, Dunne MW, Pfeffer MA. Azithromycin for the secondary prevention of coronary heart disease events. The WIZARD study: a randomized controlled trial, JAMA 2003;290:1459-66.
10. O'Donnell CJ, Levy D. Weighing the evidence for infection as a risk factor for coronary heart disease. Curr Cardiol Rep 2000;2:280-7.
11. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000;321:199-204.
12. Anon. Health strategy: quality and fairness. Dublin: Department of Health, 2001:1-700.
13. Anon. Health for all database. Geneva: World Health Organization, 2001.
14. Anon. Activity in acute public hospitals in Ireland 1990-1999. Dublin: HIPE and NPRS Unit, The Economic and Social Research Institute, 2002:188-98.
15. Anon. World Health Organization Expert Committee. Hypertension and coronary heart disease: classification and criteria for epidemiological studies. Geneva: World Health Organization, 1959.
16. Anon. Census 96: preliminary data. Dublin: Central Statistics Office, 1997.
17. Creagh D, Neilson S, Collins A, et al. Established cardiovascular diseases and CVD risk factors in a primary care population of middle-aged Irish men and women. Ir Med J 2002;95:298-301.
18. Talley NJ, Kost L, Haddad A, et al. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol 1992;30:3146-50.
19. Martins TB, Woolstenhulme RD, Jaskowski TD, et al. Comparison of four enzyme immunoassays with a western blot assay for the determination of type-specific antibodies to herpes simplex virus. Am J Clin Pathol 2001;115:272-7.
20. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies. Am Heart J 1999;138:5434-7.
21. Lip GH, Wise R, Beevers G. Association of Helicobacter pylori infection with coronary heart disease: study shows association between H pylori infection and hypertension. BMJ 1996;312:250-1.
22. Brenner H, Berg G, Frohlich M, et al. Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population-based study. Atherosclerosis 1999;147:399-403.
23. Whincup P, Danesh J, Walker M, et al. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000;101:1647-52.
24. Sorlie PD, Adam E, Melnick SL, et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J Med Virol 1994;42:33-7.
25. Ridker PM, Hennekens CH, Stampfers MJ, et al. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998;98:2796-9.
26. Roivainen M, Viik-Kajander M, Palosuo T, et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 2000;101:252-7.
27. Anderson JL, Muhlestein JB, Carlquist J, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: the azithromycin in coronary artery disease: elimination of myocardial infection with chlamydia (ACADEMIC) study. Circulation 1999;99:1540-7.
28. Neumann F, Kastrati A, Miethke T, et al. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial. Lancet 2001;357:2085-9.
29. Stone AF, Mendall MA, Kaski JC, et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames trial of antibiotics in myocardial infarction and unstable angina (STAMINA). Circulation 2002;106:1219-23.
30. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis or atherosclerosis. Circulation 2002;105:15-21.
31. Zhu J, Nieto FJ, Home BD, et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001;103:45-51.
32. Rupprecht HJ, Blankenberg S, Bickel C, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001;104:25-31.